Cannabidiol for Anxiety in Bipolar Disorder
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
- Age
- 18 – 65
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 25 (estimated)
- Sponsor
- Mclean Hospital · Other
This trial is looking for adults aged 18 to 65 with bipolar disorder and anxiety. Participants will take a high-CBD product for 4 weeks to see if it helps with their anxiety.
You may be able to join if
- I can give my consent to participate.
- I am between 18 and 65 years old.
- I speak English fluently.
- I have been diagnosed with bipolar disorder.
- I experience moderate or more anxiety.
- I am stable on my current medications.
You may not be able to join if
- I am not fluent in English.
- I have a current substance use disorder.
- I have a current or past psychotic disorder.
- I have thoughts of suicide.
- I am currently experiencing a manic or depressive episode.
- I have had a head injury that caused loss of consciousness for more than 5 minutes.
- I currently use cannabinoid products.
- I am pregnant or breastfeeding.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityPreliminary data have suggested that cannabidiol (CBD) may have a number of clinical benefits, including anti-anxiety and antidepressant properties. This study is a pilot open-label clinical trial assessing a custom-formulated high-CBD product over the course of 4 weeks in patients with bipolar disorder who experience anxiety.
Loading trial locations…